Pandharipande, Archit S.
Jain, Silky
Singh, Anuj
Verma, Shruti
Baby, Eby P.
Gaire, Hari
Bhattacharya, Sudipto
Tulsiyan, Aditi
Singh, Savitri
Radhakrishnan, Nita https://orcid.org/0000-0002-7941-5641
Article History
Received: 4 March 2025
Revised: 12 September 2025
Accepted: 17 September 2025
First Online: 2 October 2025
Declarations
:
: There is no conflict of interest.
: Institutional ethics committee approval was taken before the start of the study.
: Patient consent was taken before enrolling the patients into the study.
: Extended half-life clotting factors in management of hemophilia. Presented on 15 and 16th September, Asia pacific meeting of association of Hemophilia and allied disorders, Bangkok.